Cancer trials saved State €6.5m in drug costs - charity
Cancer Trials Ireland has said the State has saved €6.51 million in drug costs based on a sample of 38 cancer clinical trials which took place in the last 12 months.
Cancer Trials Ireland reports that the State has saved €6.51 million in drug costs over the past 12 months based on a sample of 38 cancer clinical trials. These trials involved 230 patients between September 2025 and August of this year. The charity's report, Value of Cancer Trials 2', estimates total savings, investments and revenue to the State of €23.77m.
This includes €6.51m in drug cost savings, €6.76m in inward investment from pharmaceutical companies, and €10.5m in revenue to hospitals from fee per patient payments by trial sponsors. The report also highlights that only 2.9% of cancer patients in Ireland participated in interventional trials in 2025, falling short of the national target of 6%.
Written by urgent.news from RTE News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
